Lyme disease vaccine (recombinant OspA)

a preparation of a cell surface lipoprotein of Borrelia burgdorferi, produced by recombinant technology; administered intramuscularly for active immunization against Lyme disease .

Chemwatch helps thousands of organisations manage chemical safety. Book a free demo to see how.
Book a Demo →